Free Trial
LON:CVSG

CVS Group (CVSG) Share Price, News & Analysis

CVS Group logo
GBX 1,300 +16.00 (+1.25%)
As of 12:36 PM Eastern

About CVS Group Stock (LON:CVSG)

Key Stats

Today's Range
1,270
1,306
50-Day Range
922
1,300
52-Week Range
791
1,314
Volume
605,331 shs
Average Volume
402,439 shs
Market Capitalization
£931.75 million
P/E Ratio
45.01
Dividend Yield
0.62%
Price Target
GBX 2,370
Consensus Rating
Buy

Company Overview

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses. The company also provides pet cremation and clinical waste disposal services for veterinary practices. In addition, it operates Animed Direct, an online retail business that sells prescription and non-prescription medicines, pet foods, and other pet care products; and an online dispensary. Further, the company provides burial grounds; veterinary instrumentation supply; and property development services. It owns veterinary practices, laboratories, and crematories in the United Kingdom, Australia, the Netherlands, and the Republic of Ireland. CVS Group plc was founded in 1999 and is headquartered in Diss, the United Kingdom.

Receive CVSG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS Group and its competitors with MarketBeat's FREE daily newsletter.

CVSG Stock News Headlines

Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
RBC Capital upgrades CVS Group plc (CVSG) to a Buy
Berenberg Bank Sticks to Its Buy Rating for CVS Group plc (CVSG)
See More Headlines

CVSG Stock Analysis - Frequently Asked Questions

CVS Group's stock was trading at GBX 840 at the start of the year. Since then, CVSG stock has increased by 54.8% and is now trading at GBX 1,300.
View the best growth stocks for 2025 here
.

CVS Group plc (LON:CVSG) released its quarterly earnings results on Thursday, February, 27th. The company reported $40.00 EPS for the quarter. CVS Group had a trailing twelve-month return on equity of 7.86% and a net margin of 3.20%.

Shares of CVSG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that CVS Group investors own include Meta Platforms (META), Salesforce (CRM), NVIDIA (NVDA), Pfizer (PFE), QUALCOMM (QCOM), AbbVie (ABBV) and Walt Disney (DIS).

Company Calendar

Last Earnings
2/27/2025
Today
5/09/2025

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Personal Services
Sub-Industry
N/A
Current Symbol
LON:CVSG
CIK
N/A
Fax
N/A
Employees
9,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 2,370
High Stock Price Target
GBX 2,370
Low Stock Price Target
GBX 2,370
Potential Upside/Downside
+82.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
45.01
Forward P/E Ratio
13.84
P/E Growth
1.77
Net Income
£20.68 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£646.77 million
Cash Flow
GBX 42.86 per share
Price / Cash Flow
30.33
Book Value
GBX 363.16 per share
Price / Book
3.58

Miscellaneous

Free Float
N/A
Market Cap
£931.75 million
Optionable
Not Optionable
Beta
1.02
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (LON:CVSG) was last updated on 5/9/2025 by MarketBeat.com Staff
From Our Partners